AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29072163 — intervention group
Group type: COMPARATOR
Intervention: High glycemic index breakfast
Number of subjects: 10
Study 26149441 — intervention group
Group type: EXPERIMENTAL
Intervention: Kokoro-App plus switching antidepressant
Number of subjects: 164
Study 26149441 — intervention group
Group type: COMPARATOR
Intervention: Switching antidepressant alone
Number of subjects: 164
Study 23736998 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum thymidine kinase 1 (TK1) activity
Number of subjects: 198
Study 23736998 — intervention group
Group type: EXPERIMENTAL
Intervention: CA 15‐3
Number of subjects: 198
Study 21275440 — intervention group
Group type: EXPERIMENTAL
Intervention: Trospium chloride 60 mg XR
Number of subjects: 1135
Study 21275440 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1135
Study 19738015 — intervention group
Group type: EXPERIMENTAL
Intervention: Boost Plus 8 oz (240 ml)
Number of subjects: 30
Study 19738015 — intervention group
Group type: EXPERIMENTAL
Intervention: Boost Plus 4 oz (120 ml)
Number of subjects: 30
Study 19738015 — intervention group
Group type: EXPERIMENTAL
Intervention: Boost Plus 2 oz (60 ml)
Number of subjects: 30
Study 19738015 — intervention group
Group type: EXPERIMENTAL
Intervention: Boost Plus 1 oz (30 ml)
Number of subjects: 30
Study 19738015 — intervention group
Group type: COMPARATOR
Intervention: Fasting (no Boost Plus)
Number of subjects: 30
Study 17803714 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol (600 micrograms oral)
Number of subjects: 300
Study 17803714 — intervention group
Group type: COMPARATOR
Intervention: Manual Vacuum Aspiration (MVA)
Number of subjects: 300
Study 15167287 — intervention group
Group type: EXPERIMENTAL
Intervention: Atazanavir 400 mg
Number of subjects: 346
Study 15167287 — intervention group
Group type: EXPERIMENTAL
Intervention: Atazanavir 600 mg
Number of subjects: 346
Study 15167287 — intervention group
Group type: EXPERIMENTAL
Intervention: Nelfinavir-to-atazanavir switch (400 mg)
Number of subjects: 346
Study 15167287 — intervention group
Group type: COMPARATOR
Intervention: Nelfinavir-to-atazanavir switch
Number of subjects: 346
Study 15167287 — intervention group
Group type: EXPERIMENTAL
Intervention: Atazanavir
Number of subjects: 346
Study 11232658 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative skin traction (5 pounds)
Number of subjects: 100
Study 11232658 — intervention group
Group type: COMPARATOR
Intervention: Placement of a pillow under the injured extremity
Number of subjects: 100
Study 9514180 — intervention group
Group type: EXPERIMENTAL
Intervention: Cicletanine (50 mg daily, orally)
Number of subjects: 23
Study 9514180 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 7995312 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 102
Study 7995312 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 102
Study 7995312 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide added to Lisinopril
Number of subjects: 102
Study 7995312 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide added to Nifedipine
Number of subjects: 102
Study 2738780 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent mandatory ventilation (n = 26)
Number of subjects: 53
Study 2738780 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency oscillatory ventilation (n = 27)
Number of subjects: 53
Study 30309246 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapivirine vaginal ring use
Number of subjects: 42
Study 30135733 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine position test for 3 minutes
Number of subjects: 76
Study 26751191 — intervention group
Group type: EXPERIMENTAL
Intervention: NBI-77860 300 mg
Number of subjects: 8
Study 26751191 — intervention group
Group type: EXPERIMENTAL
Intervention: NBI-77860 600 mg
Number of subjects: 8
Study 26751191 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 25499565 — intervention group
Group type: EXPERIMENTAL
Intervention: Real acupuncture at acupoint PC6
Number of subjects: 33
Study 25499565 — intervention group
Group type: COMPARATOR
Intervention: Nonpenetrating sham acupuncture
Number of subjects: 33
Study 22067277 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene (RLX)
Number of subjects: 99
Study 22067277 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Therapy (HT)
Number of subjects: 99
Study 22067277 — intervention group
Group type: COMPARATOR
Intervention: Not Treated (NT)
Number of subjects: 99
Study 19293199 — intervention group
Group type: EXPERIMENTAL
Intervention: Bosentan
Number of subjects: 32
Study 19293199 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study 17616002 — intervention group
Group type: EXPERIMENTAL
Intervention: CCGC (combined capsaicin, green tea extract, and chicken essence tablets)
Number of subjects: 6
Study 17616002 — intervention group
Group type: EXPERIMENTAL
Intervention: CCGC
Number of subjects: 6
Study 16095444 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural lidocaine (2% lidocaine, 15 ml, maintenance infusion rate of 6 ml h‐1)
Number of subjects: 30
Study 16095444 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia alone (normal saline, 15 ml, maintenance infusion rate of 6 ml h‐1)
Number of subjects: 30
Study 11888096 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal ultrasound assessment of bladder wall thickness
Number of subjects: 128
Study 11888096 — intervention group
Group type: COMPARATOR
Intervention: Ambulatory urodynamics
Number of subjects: 128
Study 9862538 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinus toxin Type A (400 mouse units injected into calf muscles)
Number of subjects: 20
Study 9862538 — intervention group
Group type: COMPARATOR
Intervention: Phenol (3 ml of 5% phenol via tibial nerve blockade)
Number of subjects: 20
Study 7654129 — intervention group
Group type: EXPERIMENTAL
Intervention: Yohimbine hydrochloride
Number of subjects: 0
Study 7654129 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine hydrochloride
Number of subjects: 0
Study 7654129 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2576432 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% D-timolol
Number of subjects: 0
Study 2576432 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% D-timolol (topical administration)
Number of subjects: 0
Study 2576432 — intervention group
Group type: EXPERIMENTAL
Intervention: D-timolol
Number of subjects: 0
Study 27719741 — intervention group
Group type: COMPARATOR
Intervention: GSK2647544 (0.5 - 750 mg single escalating oral doses)
Number of subjects: 0
Study 27719741 — intervention group
Group type: COMPARATOR
Intervention: GSK2647544 (80 mg repeat doses)
Number of subjects: 0
Study 27719741 — intervention group
Group type: COMPARATOR
Intervention: GSK2647544 with simvastatin
Number of subjects: 0
Study 31241048 — intervention group
Group type: EXPERIMENTAL
Intervention: FGG+I-PRF
Number of subjects: 40
Study 31241048 — intervention group
Group type: COMPARATOR
Intervention: FGG
Number of subjects: 40
Study 28501556 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact - owner petting and talking to the dog during the examination
Number of subjects: 33
Study 28501556 — intervention group
Group type: COMPARATOR
Intervention: Non-contact - owner present but not allowed to interact with the dog
Number of subjects: 33
Study 27331240 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates-based intervention
Number of subjects: 17
Study 27331240 — intervention group
Group type: COMPARATOR
Intervention: Standard intervention
Number of subjects: 17
Study 23455596 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (80 mg) with water
Number of subjects: 90
Study 23455596 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (80 mg) with yoghurt-based drink
Number of subjects: 90
Study 23455596 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (80 mg) with glucose-based drink
Number of subjects: 90
Study 23455596 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (80 mg) irrespective of vehicle
Number of subjects: 90
Study 20848411 — intervention group
Group type: EXPERIMENTAL
Intervention: Provox Vega voice prosthesis
Number of subjects: 31
Study 18434579 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental amalgam restoration
Number of subjects: 0
Study 18434579 — intervention group
Group type: COMPARATOR
Intervention: Mercury‐free composite resin restoration
Number of subjects: 0
Study 16963034 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended release metformin
Number of subjects: 626
Study 16963034 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate
Number of subjects: 626
Study 16963034 — intervention group
Group type: COMPARATOR
Intervention: Baseline characterization
Number of subjects: 626
Study 12937023 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycogen-depleted state
Number of subjects: 8
Study 12937023 — intervention group
Group type: COMPARATOR
Intervention: Glycogen-loaded state
Number of subjects: 8
Study 10939702 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ibuprofen 400 mg
Number of subjects: 100
Study 10939702 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral dextromethorphan 120 mg
Number of subjects: 100
Study 10939702 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of ibuprofen 400 mg and dextromethorphan 120 mg
Number of subjects: 100
Study 10939702 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 10939702 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextromethorphan alone
Number of subjects: 100
Study 9184737 — intervention group
Group type: EXPERIMENTAL
Intervention: High carbohydrate diet (68% CHO)
Number of subjects: 19
Study 9184737 — intervention group
Group type: COMPARATOR
Intervention: Normal carbohydrate diet (45% CHO)
Number of subjects: 19
Study 9184737 — intervention group
Group type: EXPERIMENTAL
Intervention: Both diets
Number of subjects: 19
Study 1350481 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol (50 mg)
Number of subjects: 0
Study 1350481 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol (100 mg)
Number of subjects: 0
Study 1350481 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 0
Study 4007027 — intervention group
Group type: EXPERIMENTAL
Intervention: Bay g 2821 (muzolimine)
Number of subjects: 0
Study 4007027 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide-amiloride
Number of subjects: 0
Study 29448219 — intervention group
Group type: EXPERIMENTAL
Intervention: Tall obstacle crossing
Number of subjects: 33
Study 29448219 — intervention group
Group type: COMPARATOR
Intervention: Tall obstacle crossing in PD group
Number of subjects: 33
Study 29448219 — intervention group
Group type: COMPARATOR
Intervention: Long obstacle crossing in PD group
Number of subjects: 33
Study 27663186 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom management (SM) drugs
Number of subjects: 244
Study 27663186 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease management (DM) drugs
Number of subjects: 244
Study 27663186 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticholinergic load (ACL)
Number of subjects: 244
Study 23716270 — intervention group
Group type: EXPERIMENTAL
Intervention: Laboratory method (direct inspection under the light microscope)
Number of subjects: 41
Study 23716270 — intervention group
Group type: COMPARATOR
Intervention: Projection method (photomicrographs of glass slides with classroom projection)
Number of subjects: 41
Study 23775187 — intervention group
Group type: EXPERIMENTAL
Intervention: Providing an interactive game during free play
Number of subjects: 0
Study 23775187 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervision and organised activities during unstructured settings
Number of subjects: 0
Study 23775187 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured (physical education) and unstructured (recess, lunch, before and after school) periods
Number of subjects: 0
Study 23775187 — intervention group
Group type: EXPERIMENTAL
Intervention: Contextual characteristics of the school environment
Number of subjects: 0
Study 19947861 — intervention group
Group type: EXPERIMENTAL
Intervention: Jamshidi 15G
Number of subjects: 87
Study 19947861 — intervention group
Group type: EXPERIMENTAL
Intervention: BIG 15G
Number of subjects: 87
Study 19947861 — intervention group
Group type: EXPERIMENTAL
Intervention: FAST1
Number of subjects: 87
Study 19947861 — intervention group
Group type: COMPARATOR
Intervention: All devices (adults overall)
Number of subjects: 87
Study 19947861 — intervention group
Group type: COMPARATOR
Intervention: All devices (children overall)
Number of subjects: 87
Study 19947861 — intervention group
Group type: COMPARATOR
Intervention: All devices
Number of subjects: 87
Study 18162083 — intervention group
Group type: EXPERIMENTAL
Intervention: IV esomeprazole 40 mg
Number of subjects: 24
Study 18162083 — intervention group
Group type: COMPARATOR
Intervention: IV lansoprazole 30 mg
Number of subjects: 24
Study 15733657 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care (descriptions of pain or undesirable experiences before procedures)
Number of subjects: 159
Study 15733657 — intervention group
Group type: EXPERIMENTAL
Intervention: Sympathizing statements after painful events
Number of subjects: 159
Study 15733657 — intervention group
Group type: COMPARATOR
Intervention: Attention control (no warnings or sympathizing statements)
Number of subjects: 159
Study 12971819 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (trained caregivers)
Number of subjects: 16
Study 12971819 — intervention group
Group type: COMPARATOR
Intervention: Control group (untrained caregivers)
Number of subjects: 16
Study 11111131 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-leaf spinach, minced spinach, liquefied spinach, liquefied spinach with dietary fibre (10 g/kg wet weight)
Number of subjects: 70
Study 11111131 — intervention group
Group type: EXPERIMENTAL
Intervention: Minced and liquefied spinach
Number of subjects: 70
Study 11111131 — intervention group
Group type: COMPARATOR
Intervention: Synthetic carotenoid supplement
Number of subjects: 70
Study 11111131 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 70
Study 8617114 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy (bismuth, metronidazole, tetracycline) for one week
Number of subjects: 112
Study 8617114 — intervention group
Group type: COMPARATOR
Intervention: Dual therapy (amoxicillin and omeprazole) for two weeks
Number of subjects: 112
Study 1411758 — intervention group
Group type: EXPERIMENTAL
Intervention: Isokinetic force/distance curve variation
Number of subjects: 44
Study 1411758 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoinertial peak force: weight ratios
Number of subjects: 44
Study 1411758 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak force‐‐weight differences
Number of subjects: 44
Study 1411758 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart rates
Number of subjects: 44
Study 1411758 — intervention group
Group type: COMPARATOR
Intervention: 50% effort
Number of subjects: 44
Study 1411758 — intervention group
Group type: COMPARATOR
Intervention: 100% effort
Number of subjects: 44
Study 6424494 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acid support
Number of subjects: 20
Study 6424494 — intervention group
Group type: COMPARATOR
Intervention: No amino acid support
Number of subjects: 20
Study 31952999 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram to predict bladder cancer diagnosis
Number of subjects: 4178
Study 31952999 — intervention group
Group type: EXPERIMENTAL
Intervention: Training cohort for logistic regression analysis
Number of subjects: 4178
Study 31952999 — intervention group
Group type: EXPERIMENTAL
Intervention: Validation cohort for receiver operating curves
Number of subjects: 4178
Study 29501296 — intervention group
Group type: EXPERIMENTAL
Intervention: Short tympanostomy tubes
Number of subjects: 378
Study 29501296 — intervention group
Group type: EXPERIMENTAL
Intervention: Long Armstrong tubes
Number of subjects: 378
Study 29501296 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone tympanostomy tubes
Number of subjects: 378
Study 29501296 — intervention group
Group type: EXPERIMENTAL
Intervention: Donaldson tubes
Number of subjects: 378
Study 29501296 — intervention group
Group type: COMPARATOR
Intervention: Infections (general)
Number of subjects: 378
Study 29501296 — intervention group
Group type: COMPARATOR
Intervention: Tube occlusion, tube extraction, persistent perforation
Number of subjects: 378
Study 26126133 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsupported sustained lumbar extension posture
Number of subjects: 24
Study 26126133 — intervention group
Group type: EXPERIMENTAL
Intervention: Supported dynamic lumbar extension posture
Number of subjects: 24
Study 26126133 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 24
Study 24076224 — intervention group
Group type: EXPERIMENTAL
Intervention: Test-drink with a favourable tryptophan/LNAA ratio
Number of subjects: 32
Study 24076224 — intervention group
Group type: EXPERIMENTAL
Intervention: Test-drink
Number of subjects: 32
Study 24076224 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 22971493 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilnidipine
Number of subjects: 50
Study 22971493 — intervention group
Group type: COMPARATOR
Intervention: L-CCB
Number of subjects: 50
Study 20935605 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise program (20 sessions of treadmill exercise starting one month after surgery)
Number of subjects: 40
Study 20935605 — intervention group
Group type: COMPARATOR
Intervention: Home exercise program (same for both groups)
Number of subjects: 40
Study 17636512 — intervention group
Group type: EXPERIMENTAL
Intervention: LigaSure haemorrhoidectomy
Number of subjects: 284
Study 17636512 — intervention group
Group type: COMPARATOR
Intervention: Diathermy haemorrhoidectomy
Number of subjects: 284
Study 16085251 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar epidural tramadol (100 mg)
Number of subjects: 40
Study 16085251 — intervention group
Group type: COMPARATOR
Intervention: Lumbar epidural morphine (4 mg)
Number of subjects: 40
Study 11967593 — intervention group
Group type: EXPERIMENTAL
Intervention: Tidal volume ventilation strategy
Number of subjects: 116
Study 11967593 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical ventilation with P(plat) levels exceeding 35 cmH(2)O
Number of subjects: 116
Study 11967593 — intervention group
Group type: COMPARATOR
Intervention: Mechanical ventilation with P(plat) lower than 35 cmH(2)O
Number of subjects: 116
Study 11156038 — intervention group
Group type: EXPERIMENTAL
Intervention: Enamel matrix derivative (EMD)
Number of subjects: 16
Study 11156038 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 9053503 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoposide phosphate (EP) at 10 mg/m2/d
Number of subjects: 23
Study 9053503 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoposide phosphate (EP) at 20 mg/m2/d
Number of subjects: 23
Study 9053503 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoposide phosphate (EP) at 25 mg/m2/d
Number of subjects: 23
Study 9053503 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoposide phosphate (EP) at 30 mg/m2/d
Number of subjects: 23
Study 9053503 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoposide phosphate (EP)
Number of subjects: 23
Study 8256303 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride rinses with 0.2% neutral sodium fluoride
Number of subjects: 1083
Study 8256303 — intervention group
Group type: COMPARATOR
Intervention: Distilled water (control group)
Number of subjects: 1083
Study 3940830 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous theophylline (100 mg) with T.E.
Number of subjects: 20
Study 3940830 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous theophylline (200 mg) with T.E.
Number of subjects: 20
Study 3940830 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous theophylline (351 mg) with T.E.
Number of subjects: 20
Study 3940830 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous theophylline (200 mg) with T.P.D.
Number of subjects: 20
Study 3940830 — intervention group
Group type: COMPARATOR
Intervention: Placebo (NaCl)
Number of subjects: 20
Study 29402513 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous platelet-rich fibrin (PRF) placed in the peri-implant region (n=21)
Number of subjects: 31
Study 29402513 — intervention group
Group type: COMPARATOR
Intervention: No augmentation (control group, n=20)
Number of subjects: 31
Study 29402513 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (PRF and control)
Number of subjects: 31
Study 27737744 — intervention group
Group type: EXPERIMENTAL
Intervention: Canakinumab 150 mg monthly for 12 months
Number of subjects: 189
Study 27737744 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 189
Study 24795254 — intervention group
Group type: EXPERIMENTAL
Intervention: RO5093151 (200 mg twice daily)
Number of subjects: 82
Study 24795254 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study 24795254 — intervention group
Group type: EXPERIMENTAL
Intervention: RO5093151
Number of subjects: 82
Study 23103618 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg of modafinil orally
Number of subjects: 49
Study 20139131 — intervention group
Group type: EXPERIMENTAL
Intervention: PTFE-coated brackets
Number of subjects: 13
Study 20139131 — intervention group
Group type: COMPARATOR
Intervention: Uncoated stainless steel brackets
Number of subjects: 13
Study 18595969 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (50000 IU)
Number of subjects: 17116
Study 18595969 — intervention group
Group type: COMPARATOR
Intervention: Placebo (oil droplets from gelatinous capsule)
Number of subjects: 17116
Study 16080445 — intervention group
Group type: EXPERIMENTAL
Intervention: Food supplemented with vitamin C (from kiwi fruits) and vitamin E (in capsules)
Number of subjects: 60
Study 16080445 — intervention group
Group type: COMPARATOR
Intervention: Plain, unsupplemented food
Number of subjects: 60
Study 12565115 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil bolus at 0.5 microg kg(‐1) and continuous infusion at 0.5 microg kg h(‐1) stopped when the tourniquet was released (Group 1, n=6)
Number of subjects: 16
Study 12565115 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil bolus at 0.5 microg kg(‐1) and continuous infusion at 0.5 microg kg h(‐1) stopped 15 minutes after tourniquet release (Group 2, n=6)
Number of subjects: 16